↓ Skip to main content

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind…

Overview of attention for article published in BMC Psychiatry, October 2013
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
133 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
Published in
BMC Psychiatry, October 2013
DOI 10.1186/1471-244x-13-253
Pubmed ID
Authors

Lenard A Adler, Bryan Dirks, Patrick Deas, Aparna Raychaudhuri, Matthew Dauphin, Keith Saylor, Richard Weisler

Abstract

This study examined the effects of lisdexamfetamine dimesylate (LDX) on quality of life (QOL) in adults with attention-deficit/hyperactivity disorder (ADHD) and clinically significant executive function deficits (EFD).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Brazil 1 <1%
Unknown 130 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 17%
Student > Ph. D. Student 14 11%
Student > Master 13 10%
Student > Postgraduate 10 8%
Researcher 8 6%
Other 30 23%
Unknown 36 27%
Readers by discipline Count As %
Psychology 34 26%
Medicine and Dentistry 29 22%
Neuroscience 6 5%
Social Sciences 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 16 12%
Unknown 40 30%